Factors Associated to Success of Hepatitis C Therapy
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the sustained virologic response (RVS) in HVC patients
treated with pegylated-interferon or conventional-interferon and ribavirin, and to
investigate the associated factors with RVS, by means of retrospective analysis.